Madison Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Madison Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.32M	Hold	2,822	–	–	0.49%	65
2023 Q2	$2.03M	Hold	2,822	–	–	0.41%	74
2023 Q1	$2.32M	Hold	2,822	–	–	0.5%	66
2022 Q4	$2.04M	Hold	2,822	–	–	0.46%	67
2022 Q3	$1.94M	Hold	2,822	–	–	0.48%	61
2022 Q2	$1.67M	Buy	2,822 +10	+0.4%	+$6.5K	0.4%	67
2022 Q1	$1.96M	Hold	2,812	–	–	0.41%	63
2021 Q4	$1.78M	Hold	2,812	–	–	0.36%	68
2021 Q3	$1.7M	Buy	2,812 +5	+0.2%	+$3.1K	0.37%	65
2021 Q2	$1.57M	Buy	2,807 +2	+0.1%	+$1.01K	0.35%	69
2021 Q1	$1.33M	Sell	2,805 -110	-4%	-$53.6K	0.32%	71
2020 Q4	$1.41M	Buy	2,915 +20	+0.7%	+$10.8K	0.37%	58
2020 Q3	$1.62M	Hold	2,895	–	–	0.49%	51
2020 Q2	$1.8M	Sell	2,895 -415	-13%	-$236K	0.59%	44
2020 Q1	$1.62M	Buy	+3,310	New	+$1.37M	0.65%	39

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Madison Wealth Management's REGN Position: Q3 2023 in Review

Madison Wealth Management held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2023 at 2,822 shares worth $2.32M. The position accounts for 0.49% of the portfolio, ranked #65.

Madison Wealth Management first reported a position in REGN in Q1 2020 and has held it in 15 quarters since. 1,178 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

Madison Wealth Management held 2,822 shares of Regeneron Pharmaceuticals worth $2.32M as of Q3 2023.
Madison Wealth Management left its Regeneron Pharmaceuticals share count unchanged in Q3 2023.
Regeneron Pharmaceuticals made up 0.49% of Madison Wealth Management's portfolio in Q3 2023, its #65 holding.
Madison Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 15 quarters since.
1,178 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Madison Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.